AC
REGN icon

Asio Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Asio Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.97M Sell
4,765
-26
-0.5% -$17.7K 0.38% 72
2026
Q1 		$3.7M Buy
4,791
+357
+8% +$273K 0.52% 58
2025
Q4 		$3.42M Buy
+4,434
New +$3.01M 0.48% 66
2025
Q2 		– Sell
-3,995
Closed -$2.53M – 116
2025
Q1 		$2.53M Buy
3,995
+477
+14% +$328K 0.49% 61
2024
Q4 		$2.51M Buy
3,518
+724
+26% +$608K 0.47% 69
2024
Q3 		$2.94M Buy
2,794
+104
+4% +$116K 0.56% 64
2024
Q2 		$2.83M Buy
2,690
+145
+6% +$141K 0.58% 61
2024
Q1 		$2.45M Buy
2,545
+43
+2% +$40.9K 0.52% 68
2023
Q4 		$2.2M Buy
2,502
+34
+1% +$28K 0.51% 71
2023
Q3 		$2.03M Buy
2,468
+198
+9% +$156K 0.54% 66
2023
Q2 		$1.63M Buy
2,270
+27
+1% +$20.8K 0.4% 80
2023
Q1 		$1.84M Buy
2,243
+86
+4% +$64.9K 0.48% 74
2022
Q4 		$1.56M Sell
2,157
-2,204
-51% -$1.63M 0.45% 77
2022
Q3 		$3M Buy
4,361
+394
+10% +$248K 0.95% 47
2022
Q2 		$2.35M Buy
3,967
+92
+2% +$59.8K 0.74% 60
2022
Q1 		$2.71M Buy
3,875
+469
+14% +$297K 0.76% 56
2021
Q4 		$2.15M Buy
3,406
+376
+12% +$231K 0.67% 67
2021
Q3 		$1.83M Buy
3,030
+658
+28% +$408K 0.63% 66
2021
Q2 		$1.32M Buy
2,372
+602
+34% +$305K 0.47% 72
2021
Q1 		$837K Buy
+1,770
New +$862K 0.35% 72

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Asio Capital's REGN Position: Q2 2026 in Review

Asio Capital reduced its Regeneron Pharmaceuticals (REGN) stake by 0.54% in Q2 2026, selling an estimated $17.7K and leaving 4,765 shares worth $2.97M. The position accounts for 0.38% of the portfolio, ranked #72.

Asio Capital first reported a position in REGN in Q1 2021 and has held it in 20 quarters since. The position peaked at $3.7M in Q1 2026. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Asio Capital held 4,765 shares of Regeneron Pharmaceuticals worth $2.97M as of Q2 2026.
  • Asio Capital sold 26 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $17.7K.
  • Regeneron Pharmaceuticals made up 0.38% of Asio Capital's portfolio in Q2 2026, its #72 holding.
  • Asio Capital first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 20 quarters since.
  • Asio Capital's Regeneron Pharmaceuticals position peaked at $3.7M in Q1 2026.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Asio Capital's 13F filing for Q2 2026, filed 17 Jul 2026.